Squarepoint’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.2M Sell
272,200
-213,900
-44% -$24.3M 0.03% 540
2025
Q4
$49M Buy
486,100
+291,300
+150% +$31.6M 0.05% 406
2025
Q3
$24M Buy
194,800
+27,900
+17% +$3.46M 0.02% 650
2025
Q2
$20M Buy
166,900
+135,600
+433% +$18.1M 0.02% 762
2025
Q1
$4.61M Sell
31,300
-61,500
-66% -$9.39M 0.01% 1475
2024
Q4
$15.1M Buy
92,800
+11,000
+13% +$1.8M 0.01% 912
2024
Q3
$13.3M Buy
81,800
+5,100
+7% +$756K 0.02% 807
2024
Q2
$10.5M Sell
76,700
-200
-0.3% -$27.8K 0.02% 922
2024
Q1
$11.8M Buy
76,900
+52,800
+219% +$7.88M 0.02% 893
2023
Q4
$3.44M Buy
24,100
+17,600
+271% +$2.35M 0.01% 1636
2023
Q3
$852K Buy
+6,500
New +$988K ﹤0.01% 2433
2023
Q1
Sell
-8,300
Closed -$1.16M 3298
2022
Q4
$1.16M Sell
8,300
-14,900
-64% -$2.11M ﹤0.01% 1717
2022
Q3
$2.98M Buy
23,200
+20,000
+625% +$2.89M 0.02% 1053
2022
Q2
$451K Buy
3,200
+500
+19% +$71.4K ﹤0.01% 2062
2022
Q1
$375K Sell
2,700
-4,100
-60% -$628K ﹤0.01% 2164
2021
Q4
$1.19M Buy
6,800
+1,000
+17% +$167K ﹤0.01% 1585
2021
Q3
$961K Buy
+5,800
New +$999K ﹤0.01% 1585

Other funds holding CLX

Squarepoint's CLX Position: Q1 2026 in Review

Squarepoint reduced its Clorox (CLX) stake by 98% in Q1 2026, selling an estimated $19.5M and leaving 3,214 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #3628.

Squarepoint first reported a position in CLX in Q2 2015 and has held it in 38 quarters since. The position peaked at $102M in Q1 2025. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Squarepoint held 3,214 shares of Clorox worth $333K as of Q1 2026.
  • Squarepoint sold 171,819 Clorox shares in Q1 2026, an estimated $19.5M.
  • Clorox made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3628 holding.
  • Squarepoint first reported a position in Clorox in Q2 2015 and has held it in 38 quarters since.
  • Squarepoint's Clorox position peaked at $102M in Q1 2025.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.